Navigation Links
Pfizer Prepares for Voluntary Withdrawal of U.S. New Drug Application and for Discontinuation of Commercial Availability of Mylotarg®
Date:6/21/2010

ction toxicity rate was significantly higher in subjects given the combination of standard induction chemotherapy and Mylotarg than in those treated with chemotherapy alone.  After extensive discussions with the FDA, Pfizer has decided to withdraw the NDA effective October 15, 2010.

"We are disappointed that the study did not confirm the clinical benefit of Mylotarg.  Our primary concern is for patients who suffer from AML, which remains a very serious and difficult-to-treat disease with limited treatment options.  We advise patients to contact their physicians for further information," said Dr. Mace Rothenberg, senior vice president of clinical development and medical affairs for Pfizer Oncology Business Unit.

Patients who are currently taking Mylotarg and those patients who have been prescribed Mylotarg may continue their course of therapy, in consultation with their physicians.  However, Pfizer recommends that no new patients in the U.S. be prescribed Mylotarg.  Future use of Mylotarg for new patients in the U.S. will require physician submission of an Investigational New Drug (IND) application to the FDA.  

The Company is also working with Health Authorities outside the U.S. and will keep patients, regulatory authorities, investigators and clinicians informed about FDA actions and appropriate next steps for Mylotarg.

For further information please contact Pfizer Medical Information at 1-800-438-1985 or at www.pfizer.com.

Mylotarg® (gemtuzumab ozogamicin for Injection) was approved in the U.S. as a single agent for patients with CD33
'/>"/>

SOURCE Pfizer Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Pfizer And Epocrates Partner To Give Healthcare Providers Access To Medical Information Specialists For Medication Questions
2. Pfizer Appoints Mikael Dolsten President of Worldwide Research and Development
3. Pfizer Invites Public to View and Listen to Webcast of Pfizer Presentation at Healthcare Conference
4. Pfizer Reigns Supreme After Patent Cliff as Humira Kicks Avastin off Top Spot
5. Gelesis Unveils Novel Non-Invasive Capsulated Device for Obesity and Presents Clinical Data; Appoints Former Pfizer R&D President to Board
6. Pfizers Jeffrey Kindler Becomes PhRMA Board Chairman; Christopher Viehbacher, John Lechleiter Assume New Posts
7. President of Pfizer Vaccines, Mark Swindell, Named as the Healthcare Businesswomens Associations 2010 Honorable Mentor
8. VetCentric Announces Partnership With Pfizer Animal Health
9. Pfizer Selects ChemAxons Markush Platform
10. Pfizer Whistleblower Named Years Most Influential Person In Business Ethics
11. Majority of Surveyed Pharmacy Directors Expect To Cover Pfizers Tanezumab If It Is Approved for the Treatment of Chronic Pain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... According to a new market ... (Endoscopes, Endoscopic Operative Devices, and Visualization Systems) - Global ... the global endoscopy devices market was valued at USD ... at a CAGR of 6.8% from 2013 to 2019, ... in 2019. Browse the full Endoscopy Devices Market ...
(Date:7/11/2014)... Neurelis, Inc. ("Neurelis") today announced an agreement ... held by Biotie to purchase Neurelis, clearing the way ... diazepam) for pediatric and adult epilepsy patients who experience ... Biotie has advanced the development program for NRL-1 and ... work required for NDA submission to the FDA.  Given ...
(Date:7/10/2014)... 2014  Breg, Inc., a premier provider of ... FreeRunner™ knee brace with new innovations to help ... return to active lifestyles.  FreeRunner,s patent-pending design acts ... support when patients need it most, and the ... Patellofemoral issues are the most common cause ...
Breaking Medicine Technology:Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 2Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 3Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 4Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 5Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 6Neurelis Regains Rights to Intranasal Diazepam Program 2Neurelis Regains Rights to Intranasal Diazepam Program 3Breg Introduces Knee Brace to Help Runners with Patellofemoral Pain Syndrome 2
... ... ... var shortURL = ""; BitlyCB.alertResponse = ... grab the first one. for (var r in data.results) { first_result = data.results[r]; break; } for (var key ...
... biotechnology specialist Azantis, Inc . has made a ... an effort to provide continued high quality service to ... SafetyCall International , Azantis has partnered with the recognized ... SafetyCall medical and toxicology professionals are ...
Cached Medicine Technology:Professor Steven V. Ley Speaks at WuXi PharmaTech 2Professor Steven V. Ley Speaks at WuXi PharmaTech 3Professor Steven V. Ley Speaks at WuXi PharmaTech 4Professor Steven V. Ley Speaks at WuXi PharmaTech 5Professor Steven V. Ley Speaks at WuXi PharmaTech 6Professor Steven V. Ley Speaks at WuXi PharmaTech 7Azantis Announces New Consumer Safety Program 2
(Date:7/12/2014)... PA (PRWEB) July 12, 2014 “After my mom’s ... then had a stroke and loss the use of his left ... to design a way to help people like them enjoy eating ... created a prototype for the PATRICIA CAROL HALL PLATE (P C ... PLATE) offers a more ergonomic way to eat for individuals who ...
(Date:7/12/2014)... York, New York (PRWEB) July 12, 2014 ... continue to move forward in U.S. courts, Bernstein Liebhard ... ties elevated metal ion levels to the failure of ... July 2nd issue of The Journal of Bone & ... had received unilateral Articular Surface Replacement prostheses at least ...
(Date:7/12/2014)... 12, 2014 For those who are unfamiliar ... readily absorb the nutrients in food. The enzymes literally break ... small enough to be absorbed by human bodies. According Dr. ... of enzymes in regular food is the cause of many ... was started by Michelle DelPresto, a mother of 3 who ...
(Date:7/12/2014)... 12, 2014 “Critical Care Therapeutics ... and Late-Stage Four-Factor PCCs and Recombinant Products to ... critical care market in the US, UK, France, ... provides an estimation of market size for 2013, ... critical care indications that are being treated using ...
(Date:7/12/2014)... (PRWEB) July 12, 2014 As reported in ... Institute of Standards and Technology), the June 25th, 2014 Supreme ... electronic discovery world. It was also met with ... depending on whether it was seen from an individual privacy ... much is fact, there is now precedent which will require ...
Breaking Medicine News(10 mins):Health News:DePuy Pinnacle Hip Lawsuit News: Bernstein Liebhard LLP Notes Release of New Study Tying Elevated Metal Ions to Metal-on-Metal Hip Failure 2Health News:DePuy Pinnacle Hip Lawsuit News: Bernstein Liebhard LLP Notes Release of New Study Tying Elevated Metal Ions to Metal-on-Metal Hip Failure 3Health News:DePuy Pinnacle Hip Lawsuit News: Bernstein Liebhard LLP Notes Release of New Study Tying Elevated Metal Ions to Metal-on-Metal Hip Failure 4Health News:New Super Digestive Enzyme, DZ10, Supercharges The Digestion Process 2Health News:Critical Care Therapeutics in Major Developed Market is Expected to Grow at a CAGR of 4.7% to $2.5 Billion in 2019 2Health News:Critical Care Therapeutics in Major Developed Market is Expected to Grow at a CAGR of 4.7% to $2.5 Billion in 2019 3Health News:Critical Care Therapeutics in Major Developed Market is Expected to Grow at a CAGR of 4.7% to $2.5 Billion in 2019 4Health News:Critical Care Therapeutics in Major Developed Market is Expected to Grow at a CAGR of 4.7% to $2.5 Billion in 2019 5Health News:Critical Care Therapeutics in Major Developed Market is Expected to Grow at a CAGR of 4.7% to $2.5 Billion in 2019 6Health News:Mobile Device Forensics Guidelines Play Key Role in Supreme Court’s Smartphone Evidence Warrant Decision 2Health News:Mobile Device Forensics Guidelines Play Key Role in Supreme Court’s Smartphone Evidence Warrant Decision 3Health News:Mobile Device Forensics Guidelines Play Key Role in Supreme Court’s Smartphone Evidence Warrant Decision 4Health News:Mobile Device Forensics Guidelines Play Key Role in Supreme Court’s Smartphone Evidence Warrant Decision 5
... you could not find the price for anything at the ... check-out clerk offered to mail you a bill, but could ... Although that sounds ridiculous, that is exactly how our nation,s ... care reform debate charges forward, the unsustainable rise in health ...
... involved with the chemopreventative effect of aspirin on colorectal adenomas, ... the Journal of the National Cancer Institute . ... polyps, but it,s not clear how it works. One hypothesis ... as C-reactive protein and others, that are markers of inflammation. ...
... might yield insights into diseases like Parkinson,s, experts say , ... genetic mutation seem to be "smarter," in the sense of ... make correct decisions quickly, a new German study suggests. , ... the prefrontal cortex of the brain, activity that is probably ...
... Oct. 12 /PRNewswire-FirstCall/ - HTDS www.htdsmedical.com (HTDS) ... Chem www.slavicabiochem.com is providing an audio recording ... Filing service. The audio recording a wav file can ... transcript and the audio recording covers scientific topics and ...
... Iowa Committee for Value in Healthcare today issued a ... health care that Congress and the Obama administration should ... The committee found that Iowa, nationally recognized for high-value ... reform. Health care providers, purchasers, payers, patient advocates and ...
... Mourning, Kidney Care Partners Call Attention to Extended Medicare ... Access to Quality Care , WASHINGTON, Oct. 12 ... advocates, dialysis professionals, care providers and manufacturers working together ... disease and kidney failure - today applauded the Congressional ...
Cached Medicine News:Health News:Regence Video Asks 'What if Everything Worked Like Health Care?' 2Health News:Regence Video Asks 'What if Everything Worked Like Health Care?' 3Health News:Gene Mutation May Speed Learning 2Health News:Slavica Bio Chem (HTDS) Subsidiary Medical Team Message 2Health News:Slavica Bio Chem (HTDS) Subsidiary Medical Team Message 3Health News:Slavica Bio Chem (HTDS) Subsidiary Medical Team Message 4Health News:Iowa Committee Makes Recommendations to Increase Value in Health Care 2Health News:Iowa Committee Makes Recommendations to Increase Value in Health Care 3Health News:Iowa Committee Makes Recommendations to Increase Value in Health Care 4Health News:Iowa Committee Makes Recommendations to Increase Value in Health Care 5Health News:Kidney Care Community Commends Congressional Black Caucus for Naming Expansion of Medicare Provisions for Kidney Failure Patients as Top Priority 2Health News:Kidney Care Community Commends Congressional Black Caucus for Naming Expansion of Medicare Provisions for Kidney Failure Patients as Top Priority 3
Diamond Point Bone Probe with Ortho-Grip® silicone rubber palm style handles and,stainless steel impactor caps....
CapSureSP Novus 5594 is a J-shaped, endocardial, tined pacing lead. provide the stable, low pacing thresholds and large sensing potentials already proven with CapSure SP steroid-eluting leads but wi...
The Guidant Fineline II Sterox Atrial J is a steroid-eluting pacing lead designed for permanent implantation for either atrial or ventricular applications....
The Guidant Fineline II Sterox is a steroid-eluting pacing lead designed for permanent implantation for either atrial or ventricular applications....
Medicine Products: